Objective
Muscoloskeletal disorder, including rheumatoid arthritis, affect millions of people in Europe and cause severe long-term pain an disability. Consequently, costs to patient and society are tremendous. As the ageing population is still growing in Europe, efficient health care of musculoskeletal disorders becomes increasingly important. It is not without reason, that the first decade of the next millennium has been declared the 'Bone and Joint Decade' OMERACT stands for 'Outcome Measures in Rheumatoid Arthritis Clinical Trials'. OMERACT is a high level scientific conference of leading experts from various health care fields, e.g. rheumatology, epidemiology, public health, pharmacology and medical technology assessment interested in outcome measurement in rheumatology. All OMERACT initiatives strive to improve the quality of applied research in rheumatology, and ultimately the quality of care of rheumatic patients in general with the aim to reduce disability and costs. OMERACT meetings are organised around leading experts and have workshop format to facilitate intensive interaction between the experts.
As OMERACT is an iterative consensus process updated every two years, it leads to scientific improvements at the cutting edge of knowledge. Participation will be limited to a maximum of 100 individuals from various countries. Most leading experts in the field of rheumatology come from the USA and Canada, but also experts from many European countries (France, Italy, Germany, Norway, UK, Sweden, Belgium, Ireland, Denmark, Spain, Switzerland, Netherlands, Finland, Poland, Bosnia-Herzegovina, and Czech Republic) participate in OMERACT. The last three OMERACT meetings were held in Canada, Australia, and Mexico, respectively. The first OMERACT meeting in the Netherland, in 1992, resulted in a enormous, stimulating impulse for rheumatology research in the Netherlands and Belgium. By organising OMERACT 5 i Toulouse, France, we hope to give a similar impulse to other
ftp://ftp.cordis.lu/pub/improving/docs/HPCF-1999-00217-1.pdf(opens in new window)
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine rheumatology
- medical and health sciences health sciences public health epidemiology
- medical and health sciences basic medicine pharmacology and pharmacy
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.